White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs — Nov 26th, 2024

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the proposal. Continue reading View comments...

Apple Tops the List of Best-Managed Companies of 2024 — Dec 9th, 2024

Tech companies hold six of the top 10 spots, while Mastercard jumped to fifth place from 24th last year. Continue reading View comments...

White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs — Nov 26th, 2024

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the proposal. Continue reading View comments...

White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs — Nov 26th, 2024

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the proposal. Continue reading View comments...

White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs — Nov 26th, 2024

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the proposal. Continue reading View comments...

White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs — Nov 26th, 2024

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the proposal. Continue reading View comments...

Galderma Bets on Skin Drug to Turn Around Pharma Business — Nov 29th, 2024

Swiss skincare company Galderma is banking on a drug for eczema treatment to revive sales growth at its pharmaceutical business and help it leave behind a hit from patent expirations. Continue reading View comments...

Sanofi Plans to Change Hospital Drug-Discount Program — Nov 22nd, 2024

The French company looks to rein in how it gives discounts in a federal program designed to help hospitals that serve low-income and uninsured patients. Continue reading View comments...

Sanofi Plans to Change Hospital Drug-Discount Program — Nov 22nd, 2024

The French company looks to rein in how it gives discounts in a federal program designed to help hospitals that serve low-income and uninsured patients. Continue reading View comments...

Sanofi Plans to Change Hospital Drug-Discount Program — Nov 22nd, 2024

The French company looks to rein in how it gives discounts in a federal program designed to help hospitals that serve low-income and uninsured patients. Continue reading View comments...

Galderma Bets on Skin Drug to Turn Around Pharma Business — Nov 29th, 2024

Swiss skincare company Galderma is banking on a drug for eczema treatment to revive sales growth at its pharmaceutical business and help it leave behind a hit from patent expirations. Continue reading View comments...

White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs — Nov 26th, 2024

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the proposal. Continue reading View comments...

The FDA Can’t Decide Whether Zepbound Is in Shortage. It’s Good News for Hims & Hers Stock. — Nov 21st, 2024

The Food and Drug Administration told a federal judge Thursday that it needs more time to reconsider whether Eli Lilly blockbuster GLP-1 drugs Zepbound and Mounjaro are in shortage. Shares of the telemedicine company Hims & Hers—which markets a compounded version of a similar medicine so...

Bitcoin Is Soaring for This Reason. Why Investors Should Beware the Crypto Rally and 5 Other Things to Know Today. — Dec 5th, 2024

Meta Platforms plans to build biggest-ever data center, Eli Lilly’s rivalry with Novo Nordisk Just ramped up, and more news to start your day. Continue reading View comments...

Sanofi Plans to Change Hospital Drug-Discount Program — Nov 22nd, 2024

The French company looks to rein in how it gives discounts in a federal program designed to help hospitals that serve low-income and uninsured patients. Continue reading View comments...

Galderma Bets on Skin Drug to Turn Around Pharma Business — Nov 29th, 2024

Swiss skincare company Galderma is banking on a drug for eczema treatment to revive sales growth at its pharmaceutical business and help it leave behind a hit from patent expirations. Continue reading View comments...

Bitcoin Is Soaring for This Reason. Why Investors Should Beware the Crypto Rally and 5 Other Things to Know Today. — Dec 5th, 2024

Meta Platforms plans to build biggest-ever data center, Eli Lilly’s rivalry with Novo Nordisk Just ramped up, and more news to start your day. Continue reading View comments...

Bitcoin Is Soaring for This Reason. Why Investors Should Beware the Crypto Rally and 5 Other Things to Know Today. — Dec 5th, 2024

Meta Platforms plans to build biggest-ever data center, Eli Lilly’s rivalry with Novo Nordisk Just ramped up, and more news to start your day. Continue reading View comments...

Sanofi Plans to Change Hospital Drug-Discount Program — Nov 22nd, 2024

The French company looks to rein in how it gives discounts in a federal program designed to help hospitals that serve low-income and uninsured patients. Continue reading View comments...

Galderma Bets on Skin Drug to Turn Around Pharma Business — Nov 29th, 2024

Swiss skincare company Galderma is banking on a drug for eczema treatment to revive sales growth at its pharmaceutical business and help it leave behind a hit from patent expirations. Continue reading View comments...

White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs — Nov 26th, 2024

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the proposal. Continue reading View comments...

Galderma Bets on Skin Drug to Turn Around Pharma Business — Nov 29th, 2024

Swiss skincare company Galderma is banking on a drug for eczema treatment to revive sales growth at its pharmaceutical business and help it leave behind a hit from patent expirations. Continue reading View comments...

Sanofi Plans to Change Hospital Drug-Discount Program — Nov 22nd, 2024

The French company looks to rein in how it gives discounts in a federal program designed to help hospitals that serve low-income and uninsured patients. Continue reading View comments...

Galderma Bets on Skin Drug to Turn Around Pharma Business — Nov 29th, 2024

Swiss skincare company Galderma is banking on a drug for eczema treatment to revive sales growth at its pharmaceutical business and help it leave behind a hit from patent expirations. Continue reading View comments...

Galderma Bets on Skin Drug to Turn Around Pharma Business — Nov 29th, 2024

Swiss skincare company Galderma is banking on a drug for eczema treatment to revive sales growth at its pharmaceutical business and help it leave behind a hit from patent expirations. Continue reading View comments...

Bitcoin Is Soaring for This Reason. Why Investors Should Beware the Crypto Rally and 5 Other Things to Know Today. — Dec 5th, 2024

Meta Platforms plans to build biggest-ever data center, Eli Lilly’s rivalry with Novo Nordisk Just ramped up, and more news to start your day. Continue reading View comments...

Galderma Bets on Skin Drug to Turn Around Pharma Business — Nov 29th, 2024

Swiss skincare company Galderma is banking on a drug for eczema treatment to revive sales growth at its pharmaceutical business and help it leave behind a hit from patent expirations. Continue reading View comments...

Sanofi Plans to Change Hospital Drug-Discount Program — Nov 22nd, 2024

The French company looks to rein in how it gives discounts in a federal program designed to help hospitals that serve low-income and uninsured patients. Continue reading View comments...

Sanofi Plans to Change Hospital Drug-Discount Program — Nov 22nd, 2024

The French company looks to rein in how it gives discounts in a federal program designed to help hospitals that serve low-income and uninsured patients. Continue reading View comments...

Sanofi Plans to Change Hospital Drug-Discount Program — Nov 22nd, 2024

The French company looks to rein in how it gives discounts in a federal program designed to help hospitals that serve low-income and uninsured patients. Continue reading View comments...

Galderma Bets on Skin Drug to Turn Around Pharma Business — Nov 29th, 2024

Swiss skincare company Galderma is banking on a drug for eczema treatment to revive sales growth at its pharmaceutical business and help it leave behind a hit from patent expirations. Continue reading View comments...

Sanofi Plans to Change Hospital Drug-Discount Program — Nov 22nd, 2024

The French company looks to rein in how it gives discounts in a federal program designed to help hospitals that serve low-income and uninsured patients. Continue reading View comments...

White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs — Nov 26th, 2024

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the proposal. Continue reading View comments...

Sanofi Plans to Change Hospital Drug-Discount Program — Nov 22nd, 2024

The French company looks to rein in how it gives discounts in a federal program designed to help hospitals that serve low-income and uninsured patients. Continue reading View comments...

Sanofi Plans to Change Hospital Drug-Discount Program — Nov 22nd, 2024

The French company looks to rein in how it gives discounts in a federal program designed to help hospitals that serve low-income and uninsured patients. Continue reading View comments...

Apple Tops the List of Best-Managed Companies of 2024 — Dec 9th, 2024

Tech companies hold six of the top 10 spots, while Mastercard jumped to fifth place from 24th last year. Continue reading View comments...

White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs — Nov 26th, 2024

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the proposal. Continue reading View comments...

Bitcoin Is Soaring for This Reason. Why Investors Should Beware the Crypto Rally and 5 Other Things to Know Today. — Dec 5th, 2024

Meta Platforms plans to build biggest-ever data center, Eli Lilly’s rivalry with Novo Nordisk Just ramped up, and more news to start your day. Continue reading View comments...

Galderma Bets on Skin Drug to Turn Around Pharma Business — Nov 29th, 2024

Swiss skincare company Galderma is banking on a drug for eczema treatment to revive sales growth at its pharmaceutical business and help it leave behind a hit from patent expirations. Continue reading View comments...

Galderma Bets on Skin Drug to Turn Around Pharma Business — Nov 29th, 2024

Swiss skincare company Galderma is banking on a drug for eczema treatment to revive sales growth at its pharmaceutical business and help it leave behind a hit from patent expirations. Continue reading View comments...

White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs — Nov 26th, 2024

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the proposal. Continue reading View comments...

Bitcoin Is Soaring for This Reason. Why Investors Should Beware the Crypto Rally and 5 Other Things to Know Today. — Dec 5th, 2024

Meta Platforms plans to build biggest-ever data center, Eli Lilly’s rivalry with Novo Nordisk Just ramped up, and more news to start your day. Continue reading View comments...

White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs — Nov 26th, 2024

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the proposal. Continue reading View comments...

White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs — Nov 26th, 2024

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the proposal. Continue reading View comments...

Galderma Bets on Skin Drug to Turn Around Pharma Business — Nov 29th, 2024

Swiss skincare company Galderma is banking on a drug for eczema treatment to revive sales growth at its pharmaceutical business and help it leave behind a hit from patent expirations. Continue reading View comments...

The FDA Can’t Decide Whether Zepbound Is in Shortage. It’s Good News for Hims & Hers Stock. — Nov 21st, 2024

The Food and Drug Administration told a federal judge Thursday that it needs more time to reconsider whether Eli Lilly blockbuster GLP-1 drugs Zepbound and Mounjaro are in shortage. Shares of the telemedicine company Hims & Hers—which markets a compounded version of a similar medicine so...

Sanofi Plans to Change Hospital Drug-Discount Program — Nov 22nd, 2024

The French company looks to rein in how it gives discounts in a federal program designed to help hospitals that serve low-income and uninsured patients. Continue reading View comments...

White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs — Nov 26th, 2024

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the proposal. Continue reading View comments...

Sanofi Plans to Change Hospital Drug-Discount Program — Nov 22nd, 2024

The French company looks to rein in how it gives discounts in a federal program designed to help hospitals that serve low-income and uninsured patients. Continue reading View comments...

White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs — Nov 26th, 2024

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the proposal. Continue reading View comments...